Special Coverage: The Buck Institute for research on aging
Buck Institute could lose $3.2M under proposed NIH cuts
National Institutes of Health funding accounts for nearly half the $36 million budget of Novato’s Buck Institute for Research on Aging.
Stem-cell advance holds promise in treating blindness
Novato researchers used stem cells to generate photoreceptors then transplanted them into blind rodents.
The Buck’s new CEO tackles aging
Eric Verdin suggests aligning Novato’s The Buck Institute for Research on Aging with organizations that could transform local advances on chronic maladies of aging into human treatments.
Novato biotech goes public via reverse merger
A Novato biotech startup found its way to public stock trading by hooking up with a cigar company.
Novato startup fights Parkinson’s with stem cells
A company founder at the Buck Institute for Research on Aging in Novato has developed stem-cell lines expected to accelerate Parkinson’s disease research.
Novato biotech startup tackles arthritis, glaucoma
Unity Biotechnology First Company in February 2016 propelled into the public arena from its home at The Buck Institute for Research on Aging in Novato.
Buck Institute launches Unity Biotechnology
The Buck Institute for Research on Aging in Novato has launched a startup called Unity Biotechnology First Company.
Writer's view on Buck Institute aging research
When you drive down Highway 101 past Novato’s Buck Institute for Research on Aging perched elegantly on the hill toward the west, now you can imagine worms, mice and brilliant scientists inside in a hive of inquiry.
Worms battle Parkinson’s, manganese
Suzanne Angeli, a postdoctoral researcher in Gordon Lithgow’s lab at Novato’s Buck Institute for Research on Aging for five years, studies Parkinson’s disease in the tiny C.
Buck research: Vitamin D extends worm lives
Maybe worms don’t get sunburns, but they appear to benefit from vitamin D, which can extend their normal 20-day lifespans.
Buck Institute partners with Google’s Calico in quest for longevity
NOVATO — The Buck Institute for Research on Aging has entered a new partnership with Google’s Calico subsidiary, deal that will set up science operations for the longevity and age-related disease venture at the institute’s Novato campus.